Patents Assigned to GenSci OrthoBiologics, Inc.
  • Reverse phase connective tissue repair composition
    Publication number: 20040022858
    Abstract: A biocompatible connective tissue repair composition which comprises a therapeutic material and a carrier comprising a means for achieving reverse phase characteristics, and methods for using said composition. The therapeutic material can be demineralized bone powder, and the carrier can be a poloxamer such as poloxamer 407.
    Type: Application
    Filed: July 28, 2003
    Publication date: February 5, 2004
    Applicant: GenSci OrthoBiologics, Inc.
    Inventor: Cameron M.L. Clokie
  • Reverse phase connective tissue repair composition
    Patent number: 6623748
    Abstract: A biocompatible connective tissue repair composition which comprises a therapeutic material and a carrier comprising a means for achieving reverse phase characteristics, and methods for using said composition. The therapeutic material can be demineralized bone powder, and the carrier can be a poloxamer such as poloxamer 407.
    Type: Grant
    Filed: August 27, 2001
    Date of Patent: September 23, 2003
    Assignee: Gensci OrthoBiologics, Inc.
    Inventor: Cameron M. L. Clokie
  • Reverse phase connective tissue repair composition
    Publication number: 20020034531
    Abstract: A biocompatible connective tissue repair composition which comprises a therapeutic material and a carrier comprising a means for achieving reverse phase characteristics, and methods for using said composition. The therapeutic material can be demineralized bone powder, and the carrier can be a poloxamer such as poloxamer 407.
    Type: Application
    Filed: August 27, 2001
    Publication date: March 21, 2002
    Applicant: GenSci OrthoBiologics, Inc.
    Inventor: Cameron M.L. Clokie
  • Bone repair material and delayed drug delivery system
    Patent number: 6311690
    Abstract: A process and product comprising collagen and demineralized bone particles. The product may contain a maximum of 20% by weight inorganic materials. The product may densified by compression. Additional osteogenic factors, mitogens, drugs or antibiotics may be incorporated therein. Inorganic materials may be bound to the organic matrix via precoating with a calcium or hydroxyapatite binding protein, peptide or amino acid. The materials also display long lasting drug release characteristics.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 6, 2001
    Assignee: GenSci OrthoBiologics, Inc.
    Inventor: Steven R. Jefferies
  • Reverse phase connective tissue repair composition
    Patent number: 6309659
    Abstract: A biocompatible connective tissue repair composition which comprises a therapeutic material and a carrier comprising a means for achieving reverse phase characteristics, and methods for using said composition. The therapeutic material can be demineralized bone powder, and the carrier can be a poloxamer such as poloxamer 407.
    Type: Grant
    Filed: September 2, 1997
    Date of Patent: October 30, 2001
    Assignee: GenSci OrthoBiologics, Inc.
    Inventor: Cameron M. L. Clokie
  • Compositions with enhanced osteogenic potential, methods for making the same and uses thereof
    Patent number: 6180606
    Abstract: Osteogenic compositions, and methods for preparing same, which compositions comprise a porous or semi-porous matrix, an osteogenic factor and an agent such as growth factors, nutrient factors, drugs, calcium-containing compounds, blood products, large molecular weight proteins, or combinations thereof. These materials can be used in a wide range of clinical procedures to replace and restore osseous or periodontal defects.
    Type: Grant
    Filed: January 13, 1998
    Date of Patent: January 30, 2001
    Assignee: GenSci Orthobiologics, Inc.
    Inventors: Charles C. Chen, Steven R. Jefferies
  • Composition with enhanced osteogenic potential, method for making the same and therapeutic uses thereof
    Patent number: 6180605
    Abstract: The present invention provides improved osteogenic compositions having enhanced by the sorption of growth factors, of nutrient factors, or drugs onto or into the compositions. Compositions may consist of collagen and demineralized bone materials onto and into which growth factors, antimicrobial agent,s nutrient factors, or other soluble factors may be sorbed to enhance the osteogenic factor. These materials can be used in a wide range of clinical procedures to replace and restore osseous or periodontal defects.
    Type: Grant
    Filed: January 5, 1998
    Date of Patent: January 30, 2001
    Assignee: GenSci OrthoBiologics, Inc.
    Inventors: Charles C. Chen, Steven R. Jeffries